2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
about
Recurrent Glioblastoma: Where we standCocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism.Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.Standards of care for treatment of recurrent glioblastoma--are we there yet?Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.Therapeutic targeting of VEGF in the treatment of glioblastoma.Angiogenesis in neurological disorders: a review.Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review.The effect of AZD2171- or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model.Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.
P2860
Q26765042-6DE21B9F-9C2D-4DF7-8D23-3FA9EA8EBCC9Q35108302-AAEBC902-2861-410B-9F75-BF47FFE2B4AEQ35836350-D9D81C47-0349-40C9-B7E8-A42918971E5BQ36130537-3E1F15ED-2C26-40F3-BDF8-8D0DBB5363D4Q36500401-A58716D3-7CC1-4DCD-8551-33E66DCDA549Q36542980-33DA1039-DFA4-4F42-8458-7509B600C951Q37858468-20DF5AA8-62B9-4C54-9462-24EEE5D9A70EQ38033241-01B07990-EB04-400D-9A1B-7B78254C9EA1Q38034321-8056048B-EC7A-4BA6-BFA3-DEFE4D273F15Q38139850-F684FFC5-512A-4371-A955-E458D7970B0FQ38607859-47594A98-59EC-4092-A54A-E14A0336250CQ38867453-9581DE31-FF76-4017-B98D-837987FDA5A2Q42143173-9D918280-2423-44FE-84B5-2CAD1FA17D54Q52802452-4CD4724F-7A06-4D9F-9866-A0441C62D70E
P2860
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@en
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@nl
type
label
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@en
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@nl
prefLabel
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@en
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@nl
P2860
P356
P1476
2010 Society for Neuro-Oncology Annual Meeting: a report of selected studies.
@en
P2093
Manmeet S Ahluwalia
P2860
P304
P356
10.1586/ERA.10.227
P577
2011-02-01T00:00:00Z